Bioanalytical Systems Inc.

16.44+1.42+9.45%Vol 86.10K1Y Perf 367.05%
Mar 19th, 2021 16:00 DELAYED
BID14.01 ASK16.60
Open14.74 Previous Close15.02
Pre-Market- After-Market-
 - -%  - -
Target Price
23.00 
Analyst Rating
— 0.00
Potential %
- 
Finscreener Ranking
★★★★ —    -
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
     38.98
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
     35.67
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Market Cap182.99M 
Earnings Rating
Buy
Price Range Ratio 52W %
0.00 
Earnings Date
13th May 2021

Today's Price Range

14.5816.47

52W Range

3.0521.08

5 Year PE Ratio Range

-66.5028.90

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
0.00%
1 Month
15.37%
3 Months
5.38%
6 Months
216.15%
1 Year
367.05%
3 Years
867.06%
5 Years
1 496.12%
10 Years
571.02%

TickerPriceChg.Chg.%
BASI16.441.42009.45
AAPL134.670.51000.38
GOOG2 300.292.53000.11
MSFT259.80-0.9400-0.36
XOM56.26-0.4000-0.71
WFC43.990.15000.34
JNJ162.630.39000.24
FB304.13-2.0500-0.67
GE13.28-0.1100-0.82
JPM152.76-0.5400-0.35
ValuationValueIndustryS&P 500US Markets
-55.70
26.69
2.74
130.80
-50.20
0.14
-190.55
0.67
233.35M
Forward PE166.88
PEG-3.71
Financial StrengthValueIndustryS&P 500US Markets
0.40
0.50
0.73
4.86
-1.30
Leverage Ratio 7.30
ProfitabilityValueIndustryS&P 500US Markets
31.50
-3.10
3.40
-4.50
-5.52
RevenueValueIndustryS&P 500US Markets
65.44M
5.88
37.46
24.90
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.19-0.0384.21
Q04 2020--0.16-
Q03 2020--0.08-
Q02 2020--0.05-
Q01 2020--0.06-
Q04 2019-0.05-
Q03 2019--0.04-
Q02 2019--0.06-
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.06--
9/2021 FY-0.21--
9/2022 FY0.09--
----
Next Report Date13th May 2021
Estimated EPS Next Report-0.06
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume86.10K
Shares Outstanding11.13M
Trades Count1.12K
Dollar Volume1.55M
Avg. Volume122.93K
Avg. Weekly Volume218.02K
Avg. Monthly Volume129.52K
Avg. Quarterly Volume128.57K

Bioanalytical Systems Inc. (NASDAQ: BASI) stock closed at 16.44 per share at the end of the most recent trading day (a 9.45% change compared to the prior day closing price) with a volume of 86.10K shares and market capitalization of 182.99M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 421 people. Bioanalytical Systems Inc. CEO is Robert W. Leasure.

The one-year performance of Bioanalytical Systems Inc. stock is 367.05%, while year-to-date (YTD) performance is 33.66%. BASI stock has a five-year performance of 1496.12%. Its 52-week range is between 3.05 and 21.08, which gives BASI stock a 52-week price range ratio of %

Bioanalytical Systems Inc. currently has a PE ratio of -55.70, a price-to-book (PB) ratio of 26.69, a price-to-sale (PS) ratio of 2.74, a price to cashflow ratio of 130.80, a PEG ratio of 2.32, a ROA of -5.61%, a ROC of -5.87% and a ROE of -38.81%. The company’s profit margin is -5.52%, its EBITDA margin is 3.40%, and its revenue ttm is $65.44 Million , which makes it $5.88 revenue per share.

Of the last four earnings reports from Bioanalytical Systems Inc., there were 1 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.06 for the next earnings report. Bioanalytical Systems Inc.’s next earnings report date is 13th May 2021.

The consensus rating of Wall Street analysts for Bioanalytical Systems Inc. is (0), with a target price of $23, which is 0.00% compared to the current price. The earnings rating for Bioanalytical Systems Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bioanalytical Systems Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Bioanalytical Systems Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 23.96, ATR14 : 1.74, CCI20 : 66.67, Chaikin Money Flow : 0.97, MACD : 0.68, Money Flow Index : 0.00, ROC : 0.00, RSI : 63.61, STOCH (14,3) : 98.41, STOCH RSI : 1.00, UO : 96.32, Williams %R : -1.59), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bioanalytical Systems Inc. in the last 12-months were: Beth A. Taylor (Buy at a value of $147 413), Beth Taylor (Buy at a value of $58 913), John E. Sagartz (Buy at a value of $17 732), John Gregory Beattie (Buy at a value of $147 875), R. Matthew Neff (Buy at a value of $47 500), Robert W. Leasure (Buy at a value of $87 097), William D. Pitchford (Buy at a value of $44 700)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating--Strong Buy
1.00

Bioanalytical Systems Inc.

Bioanalytical Systems Inc is a contract research organization that provides drug discovery and development services and analytical instruments. The company operates in two business segments namely contract research services and research products. It generates maximum revenue from the contract research services segment. The contract research services segment provides screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing. Geographically, it derives a majority of revenue from the United States and also has a presence in Other North America; Pacific Rim; Europe, and Other Countries.

CEO: Robert W. Leasure

Telephone: +1 765 463-4527

Address: 2701 Kent Avenue, West Lafayette 47906, IN, US

Number of employees: 421

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

71%29%

Bearish Bullish

59%41%

Bearish Bullish

56%44%

News

Stocktwits